Category - Developments

Developments

FDA accepts Aerie Pharma IND for dexamethasone Intravitreal Implant

The FDA accepted Aerie Pharmaceuticals’ (NASDAQ:AERI) IND for AR-1105, its dexamethasone intravitreal implant for treatment of macular edema due to retinal vein occlusion. Aerie expects to initiate a Phase 2 clinical...

January 17, 2019

Developments

Adamas Finance subscribes for $5-million of PharmaJet bonds

Adamas Finance Asia intends to subscribe for up to $5-million in a convertible bond offering by closely-held PharmaJet, the maker of needle-free injection devices. The PharmaJet injectors have received FDA approval, CE...

January 17, 2019

Developments

Canopy Growth receives NY hemp license; plans to establish U.S. commercial operations

Canopy Growth (TSX:WEED) (NYSE:CGC) received a licence from New York State to process and produce hemp and will establish large-scale hemp extraction and product manufacturing in the state. Subject to board approval of...

January 14, 2019

Developments

IntelGenx, Tilray working to launch cannabis-infused VersaFilm in late-2019

IntelGenx (TSXV:IGX; OTCQX:IGXT) updated its cannabis-infused VersaFilm product co-development program with Tilray (NASDAQ:TLRY), following recently proposed Government of Canada amendments to the Cannabis Act that...

January 14, 2019

Developments

Echelon reiterates Profound Medical as Top Pick

Echelon Wealth Partners reiterated Profound Medical’s Top Pick status (TSX:PRN; OTCQX:PRFMF) and maintained its “buy” rating and $3 price target. The stock closed at 74 cents on Jan. 9. Analyst Doug Loe writes that...

January 10, 2019

Developments

Fibrocor, Galapagos NV in development pact for fibrotic diseases

Closely-held Fibrocor Therapeutics, and Galapagos NV (Euronext, NASDAQ:GLPG), of Belgium formed a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs. In 2017, MaRs...

January 8, 2019

Developments

Canopy Growth updates U.S. hemp, CBD operations

Following passage of the U.S. 2018 Farm Bill, Canopy Growth (NYSE:CGC;TSX: WEED) provided an update of its hemp operations and expanded pathways to the American market for hemp-based products, including CBD products...

January 8, 2019

Developments

Profound Medical sees five-fold jump in preliminary Q4 revenue versus Q3

Profound Medical (TSX:PRN; OTCQX:PRFMF) expects total revenue of about $1.6-million for the fourth quarter of 2018, up from about $300,000 for the third quarter last year. For all of 2018, the company expects total...

January 4, 2019

Developments

Scientus Pharma receives Health Canada approval to sell dried cannabis

Closely-held Scientus Pharma received authorization under Health Canada’s cannabis regulations for the sale of cannabis for medical purposes and to modify its processor licence to sell dried and fresh cannabis products...

January 3, 2019

Developments

BeyondSpring has positive pre-NDA meeting at FDA about Plinabulin

BeyondSpring (NASDAQ:BYSI) had a positive pre-NDA meeting with the FDA about its lead asset, Plinabulin. The focus of this meeting was the content of the chemistry, manufacturing and control (CMC) sections of the...

December 27, 2018

Category - Developments

Subscribe